8-K: Vistagen Therapeutics, Inc. — Item 2.05 Cost Associated with Exit or Disposal Activities
Filed: 2026-10-30 AccNo: 0001628280-26-068627 Size: 140 KB Item 2.05: Cost Associated with Exit or Disposal Activities Item 8.01: Other Events
Filed: 2026-10-30 AccNo: 0001628280-26-068627 Size: 140 KB Item 2.05: Cost Associated with Exit or Disposal Activities Item 8.01: Other Events